Podcast (In Swedish) CEO Evelina Vågesjö gives an update on the companys products, clinical developments and the companys future
In press
Ilya Pharma CEO and CFO giving update in BeyondBiotech Podcast #11 in August
Beyondbiotech August episode 11, Rounding up news of the week and interviewing interesting companies - Yes also Ilya Pharma - please hear our CEO Evelina Vågesjö and CFO Oskar Lund give an update and share some details around the latests patents approved - at 29:50 to 43:00.
Ilya Pharmas progress and funding shared in context by Labiotech.eu
Cell and gene therapies are taking off in a big way in Europe. As the buzz grows, the Swedish firm Ilya Pharma has raised €8.5M to lay down the foundations of bacterial gene therapies for enterocolitis and diabetic ulcers.
Interview with our CEO Evelina Vågesjö by the MedicineMaker
Therapeutic concepts, work and science being recognised for significant contributions in the advanced therapy pipeline in the MedicineMakers PowerList 2021.
Clinical team publishes peer-reviewed expert opinion on how to optimise development of topical medicines, especially cell- and gene therapies
The team also published an expert opinion on the mechanism of actions explored and progress of pipeline in 2019 in Öhnstedt et al., Expert Opinion on Drug Discovery 2019;14(5):485-497.